Konan, Japan

Itaru Yamaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Itaru Yamaguchi. Retrieved from https://idiyas.com/inventor/itaru-yamaguchi-1x5ic0i8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Itaru Yamaguchi: Innovator in Cholinesterase Activation

Introduction

Itaru Yamaguchi is a notable inventor based in Konan-machi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on cholinesterase activators. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Yamaguchi holds a patent for a cholinesterase activator, which is crucial in enhancing the activity of cholinesterase enzymes. This invention has the potential to impact various therapeutic applications, particularly in treating conditions related to cholinergic dysfunction.

Career Highlights

Yamaguchi is currently employed at Zeria Pharmaceutical Co., Ltd., where he continues to contribute to pharmaceutical research and development. His work at Zeria has positioned him as a key player in the industry, focusing on innovative solutions that address critical health issues.

Collaborations

Throughout his career, Yamaguchi has collaborated with talented individuals such as Yoshiaki Tanaka and Naomi Kobayashi. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the development of groundbreaking inventions.

Conclusion

Itaru Yamaguchi is a distinguished inventor whose work in cholinesterase activation exemplifies the spirit of innovation in the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…